How a panel works
Standing, not recruited fresh. Engaged on demand.
- 01
Recruit
Assemble panel members in the disease and market mix you need.
- 02
Engage
Spin up touchpoints on demand: surveys, interviews, co-design.
- 03
Renew
Keep relationships warm. Come back to the same voices.
Why a standing panel
The panel is ready before the question lands
Months saved compound across a product lifecycle. Same voices across R&D, trials, and launch, instead of starting from scratch each round.
Days, not weeks
Engage your panel in 2 to 5 days, not 4 to 8.
Relationships, not recruits
Ongoing trust, less attrition, deeper context across waves.
One panel, many touchpoints
Same voices across R&D, trials, and launch.
Real-life case studies
Frequently asked questions
What is a Dedicated Patient Panel?
A standing group of trained patient experts that merakoi recruits, contracts, and operates as a ready-to-use capability for your team. Engage the panel for research, co-design, materials validation, or advisory work without rebuilding recruitment each time.
How is a dedicated panel different from one-off recruitment?
One-off recruitment resets every time: new experts, new onboarding, new contracts, no shared context. A dedicated panel keeps the same trained group engaged across many of your projects, so context and relationships compound instead of restarting.
How long does it take to set up a new dedicated panel?
Typically 6 to 10 weeks from scoping to operational, depending on disease coverage, geographic scope, and inclusion criteria. Once live, individual studies engage the panel in days, not weeks.
How does the panel evolve over the product lifecycle?
The panel composition adapts as your programme moves through clinical development, launch, and post-launch. We maintain continuity in the core group while adding patient experts whose experience matches the next phase's questions.
What can I use a dedicated panel for?
Recurring market research, co-design workshops, materials validation, label review, patient-facing content review, advisory input, trial-program work, and post-launch experience tracking. The panel is a capability, not a single study.
Book a Consultation to design your panel.
A short call to shape the panel's scope, governance split, and therapeutic composition.
